Health Headlines: Dr. Oz, FDA Updates, Pope's Progress, and More

Key health stories include Dr. Oz's stance on Medicaid, FDA's flu vaccine guidance, resignation of FDA's top lawyer, Bayer's legal win in Brazil, and the rise of measles cases in Texas and New Mexico. Also highlighted are UK's disability cost challenges and new trial for infant formula makers.


Devdiscourse News Desk | Updated: 16-03-2025 02:30 IST | Created: 16-03-2025 02:30 IST
Health Headlines: Dr. Oz, FDA Updates, Pope's Progress, and More
This image is AI-generated and does not depict any real-life event or location. It is a fictional representation created for illustrative purposes only.

In recent health news, Dr. Mehmet Oz, nominated by former President Donald Trump to oversee health programs, stated he would not oppose Medicaid cuts during his Senate Finance Committee appearance.

Meanwhile, the U.S. FDA has independently decided on virus strains for the 2025-2026 flu vaccines, departing from previous advisory votes, with no expected delay in vaccine availability.

In legal updates, Bayer secured an injunction in Brazil over a patent dispute, and a significant rise in measles cases is reported in Texas and New Mexico as an outbreak spreads.

(With inputs from agencies.)

Give Feedback